Transient Decrease in High Blood Pressure by In Vivo Transfer of Antisense Oligodeoxynucleotides Against Rat Angiotensinogen

Naruya Tomita(M4 Engineering (United States)), Toshio Ogihara(Osaka University), Yoshio Nakamura(University of Utah), Akiyoshi Fukamizu(University of Tsukuba), Yasufumi Kaneda(Osaka University), Kazuo Murakami(University of Tsukuba), Hiroshi Mikami(The University of Osaka), Ryuichi Morishita(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Motokuni Aoki(Osaka City University)
Hypertension
July 1, 1995
10.1161/01.hyp.26.1.131
Cited by 111

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
|Proceedings of the National Academy of Sciences|2010|501